| Up
2005P-0061:
DETERMINE WHEATHER THE LISTED DRUG HAS BEEN WITHDRAWN FOR SAFETY
OR EFFECTIVENESS REASONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 02/09/2005
|
| 02/09/2005
|
| Drug Industry
|
| Sun Pharmaceutical
Industries Ltd.
|
|
|
|
|
|
|
| pdf,
Attachment
|
|
|
|
|
| Signature:
|
| Anthony C. Celeste
|
|
|
|
|
| ACK1
|
| 02/09/2005
|
| 02/09/2005
|
| Federal
Government
|
| HFA-305- to AAC Consulting
Group Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Lyle Jaffe
|
|
|
|
|
|
|
|
| PAV1
|
| 03/29/2005
|
| 03/29/2005
|
| Federal
Government
|
| HFD-1 to
AAC Consulting Group & Ben Venue Laboratories Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Steven K Galson MD MPH
| |
Top
| Up
Page last updated
May 16, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
